FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2617432928> ?p ?o ?g. }

• W2617432928 endingPage "1289" @default.
• W2617432928 startingPage "1279" @default.
• W2617432928 abstract "Abstract CC‐292, a potent Bruton tyrosine kinase inhibitor, is under development for the treatment of B‐cell malignancies. An analysis was performed to develop a population pharmacokinetic model of CC‐292 and assess the influence of demographics and disease‐related covariates on CC‐292 exposure and to assess the exposure‐response (overall response rate) relationship in patients with chronic lymphocytic leukemia. Population pharmacokinetic analysis was based on a 2‐compartment base model conducted in NONMEM. Categorical exposure‐response analysis was performed using logistic regression in SAS. The population pharmacokinetic analysis results indicated that CC‐292 pharmacokinetic disposition is similar between healthy subjects and patients. CC‐292 showed a larger central compartment volume of distribution than the peripheral compartment volume of distribution (158 L and 72 L, respectively) and a faster clearance than intercompartmental clearance (134 L/h and 18.7 L/h, respectively), indicating that for CC‐292, clearance from blood occurs faster than distribution into deep tissues and organs. CC‐292 clearance is not affected by demographics or baseline clinical lab factors, except for sex. Although sex significantly reduced variation of apparent clearance, the sex effect on apparent clearance is unlikely to be clinically relevant. The exposure‐response analysis suggested that higher drug exposure is linearly correlated with higher overall response rate. A twice‐daily dose regimen showed higher overall response rate as compared to once‐daily dosing, consistent with a threshold concentration of approximately 300 ng/mL, above which the probability of overall response rate significantly increases." @default.
• W2617432928 created "2017-06-05" @default.
• W2617432928 creator A5001773431 @default.
• W2617432928 creator A5001996286 @default.
• W2617432928 creator A5027996162 @default.
• W2617432928 creator A5028218508 @default.
• W2617432928 creator A5029689967 @default.
• W2617432928 creator A5042912939 @default.
• W2617432928 creator A5069862114 @default.
• W2617432928 creator A5075592850 @default.
• W2617432928 creator A5091651670 @default.
• W2617432928 date "2017-05-19" @default.
• W2617432928 modified "2023-10-06" @default.
• W2617432928 title "Population Pharmacokinetics and Exposure Response Assessment of CC-292, a Potent BTK Inhibitor, in Patients With Chronic Lymphocytic Leukemia" @default.
• W2617432928 cites W1506889194 @default.
• W2617432928 cites W1512719441 @default.
• W2617432928 cites W1550111394 @default.
• W2617432928 cites W1836451026 @default.
• W2617432928 cites W1966083884 @default.
• W2617432928 cites W1979816280 @default.
• W2617432928 cites W1982050984 @default.
• W2617432928 cites W2008637373 @default.
• W2617432928 cites W2016455354 @default.
• W2617432928 cites W2033867789 @default.
• W2617432928 cites W2034611537 @default.
• W2617432928 cites W2057422305 @default.
• W2617432928 cites W2106665711 @default.
• W2617432928 cites W2120377900 @default.
• W2617432928 cites W2122695662 @default.
• W2617432928 cites W2134620914 @default.
• W2617432928 cites W2160367702 @default.
• W2617432928 cites W2164506198 @default.
• W2617432928 cites W2346748817 @default.
• W2617432928 cites W2414136623 @default.
• W2617432928 cites W2535927310 @default.
• W2617432928 cites W2551912396 @default.
• W2617432928 cites W975985626 @default.
• W2617432928 doi "https://doi.org/10.1002/jcph.923" @default.
• W2617432928 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5599992" @default.
• W2617432928 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28543084" @default.
• W2617432928 hasPublicationYear "2017" @default.
• W2617432928 type Work @default.
• W2617432928 sameAs 2617432928 @default.
• W2617432928 citedByCount "10" @default.
• W2617432928 countsByYear W26174329282018 @default.
• W2617432928 countsByYear W26174329282019 @default.
• W2617432928 countsByYear W26174329282021 @default.
• W2617432928 countsByYear W26174329282022 @default.
• W2617432928 countsByYear W26174329282023 @default.
• W2617432928 crossrefType "journal-article" @default.
• W2617432928 hasAuthorship W2617432928A5001773431 @default.
• W2617432928 hasAuthorship W2617432928A5001996286 @default.
• W2617432928 hasAuthorship W2617432928A5027996162 @default.
• W2617432928 hasAuthorship W2617432928A5028218508 @default.
• W2617432928 hasAuthorship W2617432928A5029689967 @default.
• W2617432928 hasAuthorship W2617432928A5042912939 @default.
• W2617432928 hasAuthorship W2617432928A5069862114 @default.
• W2617432928 hasAuthorship W2617432928A5075592850 @default.
• W2617432928 hasAuthorship W2617432928A5091651670 @default.
• W2617432928 hasBestOaLocation W26174329281 @default.
• W2617432928 hasConcept C112705442 @default.
• W2617432928 hasConcept C126322002 @default.
• W2617432928 hasConcept C139254425 @default.
• W2617432928 hasConcept C2776239304 @default.
• W2617432928 hasConcept C2777288759 @default.
• W2617432928 hasConcept C2777938653 @default.
• W2617432928 hasConcept C2778461978 @default.
• W2617432928 hasConcept C2908647359 @default.
• W2617432928 hasConcept C71924100 @default.
• W2617432928 hasConcept C90924648 @default.
• W2617432928 hasConcept C98274493 @default.
• W2617432928 hasConcept C99454951 @default.
• W2617432928 hasConceptScore W2617432928C112705442 @default.
• W2617432928 hasConceptScore W2617432928C126322002 @default.
• W2617432928 hasConceptScore W2617432928C139254425 @default.
• W2617432928 hasConceptScore W2617432928C2776239304 @default.
• W2617432928 hasConceptScore W2617432928C2777288759 @default.
• W2617432928 hasConceptScore W2617432928C2777938653 @default.
• W2617432928 hasConceptScore W2617432928C2778461978 @default.
• W2617432928 hasConceptScore W2617432928C2908647359 @default.
• W2617432928 hasConceptScore W2617432928C71924100 @default.
• W2617432928 hasConceptScore W2617432928C90924648 @default.
• W2617432928 hasConceptScore W2617432928C98274493 @default.
• W2617432928 hasConceptScore W2617432928C99454951 @default.
• W2617432928 hasIssue "10" @default.
• W2617432928 hasLocation W26174329281 @default.
• W2617432928 hasLocation W26174329282 @default.
• W2617432928 hasLocation W26174329283 @default.
• W2617432928 hasLocation W26174329284 @default.
• W2617432928 hasOpenAccess W2617432928 @default.
• W2617432928 hasPrimaryLocation W26174329281 @default.
• W2617432928 hasRelatedWork W2019022133 @default.
• W2617432928 hasRelatedWork W2082998857 @default.
• W2617432928 hasRelatedWork W2090307551 @default.
• W2617432928 hasRelatedWork W2155041980 @default.
• W2617432928 hasRelatedWork W2328085100 @default.
• W2617432928 hasRelatedWork W2367999783 @default.
• W2617432928 hasRelatedWork W2391487123 @default.

• next